John M.S. Bartlett
Ontario Institute for Cancer Research(CA)University Health Network(CA)Western General Hospital(GB)Edinburgh Cancer Research(GB)Princess Margaret Cancer Centre(CA)Atlantic Technological UniversityInstitute of Technology Sligo(IE)University of Edinburgh(GB)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Pancreatic and Hepatic Oncology Research, Estrogen and related hormone effects
Most-Cited Works
- → Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update(2013)4,028 cited
- → Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer(2017)2,447 cited
- → Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update(2018)2,381 cited
- → Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials(2017)1,112 cited
- → Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group(2020)688 cited
- → Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution